Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Anemia

Free Subscription 06.02.2023 1 Am J Hematol 1 Am J Obstet Gynecol 4 Ann Hematol 4 Blood 1 BMC Cancer 1 BMJ 2 Haematologica 1 Int J Hematol 2 Lancet 1 Pediatr Rev 3 PLoS One 2 Transfusion

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. GLASPY J, Gabrail NY, Locantore-Ford P, Lee T, et al
   Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies.
   Am J Hematol. 2023 Jan 29. doi: 10.1002/ajh.26865.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

2. MUNRO MG, Mast AE, Powers JM, Kouides PA, et al
   The Relationship between Heavy Menstrual Bleeding, Iron Deficiency, and Iron Deficiency Anemia.
   Am J Obstet Gynecol. 2023 Jan 24:S0002-9378(23)00024.
   PubMed         Abstract available
   
   

   
   Ann Hematol

3. TANTAWY A, El-Sherif N, Makkeyah S, Eldeen NS, et al
   Sleep disordered breathing and its relation to stroke and pulmonary hypertension in children with sickle cell disease: a single-center cross-sectional study.
   Ann Hematol. 2023 Jan 16. doi: 10.1007/s00277-023-05099.
   PubMed         Abstract available
   
   
4. WANG H, Liu H, Li L, Chen Y, et al
   Long noncoding RNA FAM157C contributes to clonal proliferation in paroxysmal nocturnal hemoglobinuria.
   Ann Hematol. 2023;102:299-309.
   PubMed         Abstract available
   
   
5. FU X, Zhao X, Weng A, Zhang Q, et al
   Comparative efficacy and safety of restrictive versus liberal transfusion thresholds in anemic preterm infants: a meta-analysis of 12 randomized controlled trials.
   Ann Hematol. 2023;102:283-297.
   PubMed         Abstract available
   
   
6. MELONI A, Pistoia L, Quota A, Messina G, et al
   Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients.
   Ann Hematol. 2023;102:261-270.
   PubMed         Abstract available
   
   

   
   Blood

7. PARROW NL, Fleming RE
   Transferrin receptor 1: keeper of HFE.
   Blood. 2023;141:332-333.
   PubMed        
   
   
8. TARFI S, Badaoui B
   Four genetic red cell disorders in one.
   Blood. 2023;141:436.
   PubMed        
   
   
9. XIAO X, Moschetta GA, Xu Y, Fisher AL, et al
   Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in beta-thalassemia.
   Blood. 2023;141:422-432.
   PubMed         Abstract available
   
   
10. HULBERT ML, Fields ME, Guilliams KP, Bijlani P, et al
    Normalization of cerebral hemodynamics following hematopoietic stem cell transplant in children with sickle cell disease.
    Blood. 2022 Aug 30. pii: 486449. doi: 10.1182/blood.2022016618.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. CONNOR JP, Destrampe E, Robbins D, Hess AS, et al
    Pre-operative anemia and peri-operative transfusion are associated with poor oncologic outcomes in cancers of the esophagus: potential impact of patient blood management on cancer outcomes.
    BMC Cancer. 2023;23:99.
    PubMed         Abstract available
    
    

    
    BMJ

12. KMIETOWICZ Z
    Patients with sickle cell disease are let down by lack of coordinated NHS care, report finds.
    BMJ. 2023;380:257.
    PubMed        
    
    

    
    Haematologica

13. HE Y, Guo X, Wang ZJ
    Therapeutic potential of beta-lactam ceftriaxone for chronic pain in sickle cell disease.
    Haematologica. 2023;108:633-637.
    PubMed        
    
    
14. RAI P, Okhomina VI, Kang G, Akil N, et al
    The effects of cardio-selective beta blockade on diastolic dysfunction in children with sickle cell disease.
    Haematologica. 2023;108:594-598.
    PubMed        
    
    

    
    Int J Hematol

15. PIYAJAROENKIJ T, Tantiworawit A, Khikhuntod J, Piriyakhuntorn P, et al
    Alteration of monocyte subsets and their functions in thalassemia patients.
    Int J Hematol. 2023;117:188-197.
    PubMed         Abstract available
    
    

    
    Lancet

16. VERSTOVSEK S, Gerds AT, Vannucchi AM, Al-Ali HK, et al
    Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
    Lancet. 2023;401:269-280.
    PubMed         Abstract available
    
    
17. IKEDA K, Ueda K
    Gaining MOMENTUM against anaemic myelofibrosis.
    Lancet. 2023;401:248-249.
    PubMed        
    
    

    
    Pediatr Rev

18. TREGONING VG, Parran K, Watson AS, Mitchell ML, et al
    Refractory Pneumonia in a 12-year-old Girl with Hemoglobin SS Disease.
    Pediatr Rev. 2023;44:100-103.
    PubMed        
    
    

    
    PLoS One

19. SHARIF N, Das B, Alam A
    Prevalence of anemia among reproductive women in different social group in India: Cross-sectional study using nationally representative data.
    PLoS One. 2023;18:e0281015.
    PubMed         Abstract available
    
    
20. TADEREGEW MM, Wondie A, Terefe TF, Tarekegn TT, et al
    Anemia and its predictors among chronic kidney disease patients in Sub-Saharan African countries: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0280817.
    PubMed         Abstract available
    
    
21. ASMAR J, Chelala D, El Hajj Chehade R, Azar H, et al
    Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study.
    PLoS One. 2023;18:e0280871.
    PubMed         Abstract available
    
    

    
    Transfusion

22. GHESQUIERE L, Leroy J, Deken V, Tournier A, et al
    Anti-RH1 alloimmunization: At what maternal antibody threshold is there a risk of severe fetal anemia?
    Transfusion. 2023 Feb 3. doi: 10.1111/trf.17264.
    PubMed         Abstract available
    
    
23. TRAN A, Yan MTS, Branch DR, Blacquiere M, et al
    Severe fetal anemia caused by anti-Jr(a) : Burst forming unit-erythroid colony formation inhibition assay suggesting possible erythroid suppression mechanism.
    Transfusion. 2023 Feb 2. doi: 10.1111/trf.17265.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: